Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Establishment of a Diagnosis, Treatment, and Prevention System for Colorectal Cancer Under the Background of Abnormal Lipid Metabolism in Digitalization

NCT06886022 is registered in ClinicalTrials.gov with Tianjin Union Medical Center as lead sponsor.

NCT NCT06886022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06886022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Establishment of a Diagnosis, Treatment, and Prevention System for Colorectal Cancer Under the Background of Abnormal Lipid Metabolism in Digitalization
Lead sponsor
Tianjin Union Medical Center
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2017
Completion date
December 31, 2028
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer